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Abstract
Background: The Israel Defense Forces Medical Corps (IDF MC) institutional review board (IRB) is one of approximately
50 IRBs active in Israel. In addition to routine IRB considerations it must also address in its deliberations specific safeguards
in place in the IDF to protect research volunteers in the military environment. In this report, we present the characteristics
of the IDF IRB, including the unique circumstances that led to a 2008 change in the pre-IRB advisory and preparatory
process (APP). We also present quantitative data on the IRB’s throughput and outcomes, in order to provide a benchmark
for other IRBs.
Methods: We reviewed all relevant IDF regulations, both historical and current, pertaining to the structure, activity and
oversight of the IRB and of medical research conducted in the IDF. Additionally, we analyzed the ethical review process
for all research proposals submitted to the IDF APP between January 1, 2013 and December 31, 2015.
Results: In 2008 the IDF implemented several major changes which have had a substantial impact on the ethical
regulation of military medical research. The period following these changes has seen a rise in the number of research
proposals submitted to the IDF IRB annually. During the years 2013–2015, 377 research proposals entered the APP, of
which 329 were deemed appropriate for IRB deliberation. Eight study protocols were granted waivers, 19 were rejected,
and the remaining 302 were authorized. Overall, 345 of the 377 research proposals submitted (92 %) were ultimately
cleared for execution; 310 of 329 proposals (94 %) deliberated by the IRB were authorized. The IRB required protocol
revisions for 47 % of the research proposals, one-third of which were revisions directly associated with military-specific
ethical precautions.
Conclusions: Guided by the principles of protecting personal autonomy in the complex military setting, the IDF has
implemented several unique measures aimed at maintaining the highest ethical standards in medical research. By sharing
research approval process data similar to those presented here, medical institutions can help build and support a
peer-based benchmarking process through which individual IRBs can appraise their own processes and approval rates.
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Background
In August 1947, a US military court reached a decision
on the Nuremberg Trials of doctors involved in conduct-
ing human experiments in the Nazi concentration
camps. In their decision, the justices cited 10 points,
later termed the Nuremberg Code, that set the standard
for human subject medical research to this day [1]. The
Nuremberg Code addresses issues such as informed con-
sent, avoidance of unnecessary pain and suffering, and
maintaining the subject’s right to cease participation in
the study at any time. This code has since gained sub-
stantial standing in the field of medical ethics, yet it has
never become codified in law. The Geneva declaration
of 1948 [2] further underscored the physician’s responsi-
bilities towards his patients and the guaranteeing of his
health and well-being, while only in 1964, during the
18th meeting of the World Medical Association, was a
declaration issued specifically addressing the guiding
principles of human research [3]. This “Helsinki Declar-
ation” underwent several revisions over time, until the
concept of an independent institutional review board
(IRB) was introduced in 1975. In 1981, the requirement
of an IRB was included in US federal law [4].
In Israel today, the statutory status of the IRB is rooted
in a public health regulations dating from 1980 [5].
Medical institutions in Israel, such as hospitals and the
IDF, maintain IRBs. Recent estimates place the number
of active IRBs in Israel today at 53 (N.P. - personal com-
munication), including that of the IDF MC. The IDF’s
IRB supports an active and robust research effort, which
includes 13 permanent research programs and hundreds
of individual research projects at any point in time
(Fig. 1).
Medical research in the IDF dates back to the 1950s,
although many of the results of these early studies were
not published in the scientific literature. Throughout the
1980s and early 1990s military medical research experi-
enced a rapid growth in the IDF, and more of the results
appeared in scholarly medical journals. Common fields of
interest for military medical researchers have routinely in-
cluded combat casualty care (such as hemorrhage control
and triage tools), warrior physiology (such as heat and
cold injury, overuse injury and hypobaric and hyperbaric
medicine) and soldier health (such as preventive medicine,
occupational health and military psychiatry).
Most IDF research subjects, mainly military personnel,
are intrinsically and fundamentally different than their
civilian counterparts. The majority of IDF soldiers are
aged 18–21 years and have only recently reached the age
of legal adulthood. Additionally, they serve in a highly
hierarchical setting, are acutely susceptible to peer pres-
sure, and are strongly influenced by, and dependent on,
their superiors. Due to these constrictions, some soldiers
may feel compelled to volunteer for research studies if
asked to do so, due to concerns that non-participation
might result in negative action by commanders. Further-
more, soldiers are not at liberty to choose their own
medical care givers, and military physicians might find
themselves in a conflict of interest between their respon-
sibilities as care givers and their responsibilities as re-
searchers. Finally, most IDF soldiers serve in the military
under mandatory conscription laws and not necessarily
of their own free will, which adds an additional protect-
ive responsibility to the military establishment. Together,
these unique characteristics require that special practices
be implemented in order to maintain the ethical stan-
dards mandated for all human subject research.
Military medical research is not a unique feature of
the IDF. The United States Army Institute of Surgical
Research (USAISR) has also explored ethical issues char-
acteristic of military research [6]. USAISR has an advis-
ory panel to assist researchers and decrease IRB burden,
but this effort is concentrated mainly on the difference
between “performance improvement” (meaning the
evaluation of procedures that are part of common prac-
tice and hence do not require an IRB approval), and
Fig. 1 IDF MC 13 permanent research programs
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“research” (which is defined as the “testing of issues that
go beyond medical knowledge…”) [6]. It is interesting to
note that within this US context, and in contrast with
the IDF, the fact that research subjects are soldiers or
veterans is not considered an issue in need of special
consideration. This difference may be due to the fact
that the IDF is a conscription-based army, while the US
army, and indeed the majority of western armies, are
volunteer-based.
In this report, we aim to present the history of the IDF
regulations on human research that led to the creation of
the unique advisory and preparatory process (APP); de-
scribe the qualitative characteristics of the IDF’s IRB; and
provide quantitative data on the IRB’s throughput and
output, in order to provide a benchmark for other IRBs.
Methods
We reviewed all relevant IDF regulations and orders per-
taining to the structure, activity and oversight of the IRB
and of medical research conducted in the IDF. Addition-
ally, we analyzed the ethical review process for all re-
search proposals submitted to the IDF APP between
January 1, 2013 and December 31, 2015. We reviewed
all IRB protocols for this period, and recorded specific
notes and considerations cited for each IRB decision.
We calculated IRB rejection rates, approval rates and re-
vision rates, and categorized and quantified IRB requests
for protocol revisions. We also calculated the APP’s ef-
fectiveness in reducing IRB burden. This study was
granted an IRB waiver by the IDF medical corp’s IRB, as
no personal subject data were collected or used.
Results
The history of the IDF MC IRB
From 1980 through the late 2000s, medical research in
the IDF was regulated in accordance with Israel Ministry
of Health regulations [5]. In 2007, the issue of human
subject medical research in the IDF received widespread
public attention in response to a television expose that
reported on a previously unpublicized clinical trial con-
ducted in the IDF between 1999 and 2005 [7]. According
to this report, 716 soldiers from elite IDF units volun-
teered to participate in a phase II clinical study to test
the efficacy of a vaccine against anthrax, in anticipation
of the potential threat of this pathogen within the con-
text of biological warfare. Several dozen of these volun-
teers later complained of various side effects which they
attributed to having received the study vaccine [8].
Public debate surrounding the controversy focused on
several key ethical issues relating to the conduct of med-
ical research in the military setting, including the justifi-
cation for recruiting soldier volunteers, the ethics of
conducting confidential medical research and the ability
of soldiers to provide informed consent. During the
ensuing debate a petition was filed with the Supreme
Court to issue an injunction to curtail all medical re-
search in the IDF, and the Israel Medical Association
submitted an amicus brief to the court suggesting that
soldiers are vulnerable subjects and should therefore be
disqualified from participating in medical research [9].
In 2008 the IDF Surgeon General initiated a major revi-
sion of the military orders governing medical research,
in response to which the Supreme Court petition was
withdrawn. To date, medical research in the IDF con-
tinues under this revised set of military regulations.
In order to protect IDF personnel within the context
of human subjects research, as well as to help IDF med-
ical researchers maintain the highest standards of ethical
research, the IDF MC has established two complemen-
tary mechanisms that together form the oversight and
regulatory framework that governs military medical re-
search. The first mechanism is the IDF IRB, which func-
tions in accordance with IDF Supreme Command
Directive 2.0716 and IDF Surgeon General’s Directive
100.013 [10]. These military regulations are generally
considered stricter and more conservative than the com-
parable guidelines that govern civilian IRBs, especially
concerning on the following:
 Limitations on volunteer recruitment and
recruitment setting (in cases where the study
carries more than minimal risk for the solider,
the researcher cannot approach the research
subjects directly, and has to wait for the subjects
to approach the researchers),
 Establishment of upper limits on recruitment rates,
 Prohibition of commander presence at the
recruitment site,
 Burden of proof to demonstrate direct military
relevance and benefit to soldier health;
 Composition of the IRB, which must include two
high-level retired military personal that have
substantial academic backgrounds in a non-medical
topics and whose role is to try and change the
research population from army-based to civilian-based.
In addition to the protective mechanisms presented
above, additional safeguards have been put in place in
the IDF to protect study subject welfare under special
circumstances. When the study population includes
soldiers in basic training, the researcher must demon-
strate to the IRB that the study can be done only in this
population group and that it will help this group specif-
ically. If this criterion is not met, the IRB will not ap-
prove the study.
Since a small proportion of military medical research
might be classified for security reasons, subjects entering
such a study might logically be limited in their ability to
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consult with others regarding their ongoing participa-
tion. In order to ensure transparency and full access to
consultation, current IDF regulations stipulate that all
classified studies must identify an independent, non-
military consulting physician to whom all study subjects
must have unlimited access at all times. This independent
consultant can answer any subject questions that arise be-
fore, during or after the study, and can assist subjects in
reaching a decision regarding their participation and con-
sult regarding concerns about potential side effects.
In cases where the study carries more than minimal
risk for the solider, the recruitment team of the study
cannot enroll soldiers directly. Rather, once the study
has been presented to the target group, soldiers inter-
ested in enrolling in the study must initiate the contact
with the recruitment team.
The second mechanism put in place in 2008 is the
APP, which precedes the deliberation by the IRB. This
preparatory process includes early guidance by the IRB
secretary, medical specialists, research consultants, tech-
nical writers, and legal counsel, who together help re-
searchers prepare for and meet the rigorous ethical,
academic and scientific standards required by the IDF
and its IRB.
Review of the APP role
The fundamental idea and the most important function of
the APP is to ensure the maintenance of ethical standards
in IDF research protocols. However, the APP has acquired
other functions over the time. First, as the APP has be-
come a mechanism to exclude un-ethical or non-relevant
proposals, it also reduces the workload of the IRB. Second,
the APP assists researchers who wish to conduct their re-
search in the IDF but do not have the knowledge of the
required technical and ethical standards, by escorting the
researcher from the basic research idea to a full proposal
that meets IRB demands. Third, the APP assists re-
searchers who already have a full research protocol “fine
tune” it to the specific demands of the IDF IRB.
The integrative structure of the APP and its relation-
ship with the IRB are shown in Fig. 2. It is notable that
before any research protocol is deliberated by the IRB, it
is sent to the APP for discussion of any potential ethical,
technical and professional difficulties. Only after the
APP has reviewed and approved the research protocol is
it submitted to the IRB for formal deliberation. If a re-
search protocol is not approved by the IRB, it returns to
the APP to assist the investigators in making any
changes or improvements that are necessary before it
can be resubmitted to the IRB.
IRB throughput and output
From 2002 through 2007, an average of 91 proposals were
introduced to the IRB annually. Since the introduction of
the APP in 2008 and through 2015, this annual average in-
creased to 115. Between January 2013 and December
2015, the APP handled a total of 377 research proposals
(Fig. 3). Upon initial review, 35 proposals were found to
be exempt from IRB authorization and were granted
waivers, while 13 study proposals were found to be in-
appropriate for execution in the IDF due to insurmount-
able flaws that precluded meeting ethical, academic or
scientific standards. The remaining 329 proposals were
deemed appropriate and were prepared for IRB deliber-
ation. The IRB subsequently determined that eight of
these study protocols were, in fact, entitled to waivers. 19
proposals were rejected, and the remaining 302 were au-
thorized. Of the 377 research proposals submitted to the
APP during 2013–2015, 345 (92 %) were ultimately
cleared for execution, while 310 of 329 proposals (94 %)
deliberated on by the IRB were cleared for execution.
Of the 302 research proposals ultimately approved by
the IRB after deliberation, 134 (44 %) required 190 sep-
arate protocol revisions, of which 62 (33 %) were revi-
sions directly associated with the additional precautions
in place for military research volunteers (Table 1). The
remaining 168 research proposals (56 %) were approved
by the IRB with no need for protocol revisions.
Fig. 2 Advisory and preparatory process (APP) and Institutional
Review Board (IRB) work flow algorithm
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Protocol revisions were required for various reasons.
Of the 54 revision requirements related to informed
consent, 40 were technical and required the investigator
to add a simple, clear-cut declaration to the informed
consent forms such “refusing to be a part of this study
will not interfere with my military service” or “I under-
stand that I do not have to take part in this study”. Ten
revisions addressed the possibility that, during the study,
the researcher might discover medical information that
would require the exclusion of the soldier from his
current military training assignment due to health re-
strictions. In these cases, the consent form was required
to include an additional statement such as: “By taking
part in this research I understand that new medical in-
formation about me may become available to the IDF
MC, and that the discovery of such information may,
under certain circumstances, jeopardize the continuity
of my current military training assignment.” The
remaining four informed consent revisions were related
to studies that required the participant to use a medica-
tion, placebo or medical device. In these cases, the IRB
required specifically tailored protocol revisions, includ-
ing the following: that enrollment of mandatory service
soldiers be limited to those in their final year of service;
that the consent form specifically state that the study
protocol requires the participant to perform a task that
is not a part of his regular training and to list the added
training required; and that the consent form specifically
state that participating in the study will not provide the
participant better accessibility to medical treatment.
Eight protocol revision requirements addressed issues
relating to the method of solider enrollment. One revi-
sion required the researcher to recruit subjects from a
more varied array of military units than originally pro-
posed. Three study protocols involved the testing of
defense products intended for use by both soldiers and
civilians, and the IRB required a change to the enroll-
ment ratio of these two populations. Two studies were
initially intended for execution among basic trainees, but
the IRB required that the enrollment be from the general
military population. One revision addressed the issue of
peer pressure among a specific group of soldiers targeted
for enrollment, and the final revision required the ap-
pointment of an independent external consultant for a
non-classified research study, due to the nature of the
study topic and the target population.
Nineteen proposals were approved in the APP screen-
ing process but were eventually rejected by the IRB. Six
proposals were denied due to limitations relating to data
security. Four proposals were denied when the IRB be-
came convinced that the potential risk to the enrolled
solider outweighed the potential for personal benefit.
One study was denied when concerns were raised that
conducting it during a training course might comprom-
ise soliders’ ability to provide informed consent. Two
studies were rejected on the grounds that they planned
to consume a unique and limited resource best reserved
for other purposes, and six were rejected as “not in the
interest of the IDF MC”.
Discussion
The unique aspects of the military environment and the
ethical considerations regarding the recruitment of sol-
dier volunteers for medical research require military
IRBs to remain especially vigilant in protecting research
subjects and in holding military researchers to the high-
est ethical standards of conduct. This is especially true
for research conducted on basic trainees, who are even
more dependent on their superiors, highly subject to
peer pressure, and less able to provide true informed
consent. Thus, in the IDF the IRB carefully parses all re-
search proposals in order to ensure that they meet the
Table 1 Distribution of institutional review board requests for
protocol revisions (N = 134 research proposals)
Reason for revision request Military-specific
request
Number
Inadequate provisions for informed consent
by soldiers
Yes 54
Inadequate justification for soldier enrollment Yes 8
Inadequate assurance of subject anonymity No 37
Scientific issues regarding research methods No 44
















Fig. 3 Advisory and preparatory process (APP) and Institutional
Review Board (IRB) work flow and decision outcomes, 2013–2015
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strict military regulations regarding subject recruitment
and military relevance. Recruitment rates among trainees
is capped at 80 %, so that soldiers declining to provide
consent for participation are “masked” by arbitrarily
excluded subjects. Training cadre are excluded from re-
cruitment meetings in order to prevent any undue influ-
ence of their presence on soldier consent. Additionally,
military clinicians are prohibited from enrolling soldiers
under their care as participants in clinical trials, and re-
searchers wishing to recruit potential subjects must pro-
vide a 48 h waiting period between initial contact and
signing of the consent form, in order to allow soldiers
ample time to consult with family or friends.
The ultimate goal of medical research is to promote
solutions to health related issues that currently lack sat-
isfactory solutions. Since the military population and its
health-related issues are inherently different from those
of the civilian population, there is a real need to conduct
research on this specific population, especially on topics
where there is a cardinal difference between soldiers and
civilians. Ethical medical research in a conscript-based
army requires special consideration and care, mostly due
to the soldier’s potentially limited ability to provide
genuine informed consent. This principle is central to
the rationale for the existence of the APP and the mili-
tary IRB. For each research proposal submitted for ap-
proval in the military, the regulatory bodies must
address several unique questions: Must this research be
done specifically on soldier subjects? Can it be done on
civilians instead? Will this research proposal ultimately
benefit the soldier population? How will the investiga-
tors assure that genuine informed consent is given?
While the rationale behind the heightened vigilance of
the IDF IRB is clear, it remains difficult to quantify the
impact of these measures. Although technical aspects of
IRB processes, such as turnaround time from proposal
submission to researcher notification, have been de-
scribed previously [11], there is no simple method to
quantify the ethical oversight provided by institutions in
the regulation of medical research [12]. A systematic re-
view by Edwards et al. described 26 publications that
compared ethical judgments across IRBs [13]. Their
study found that when separate IRBs deliberated identi-
cal research protocols within the context of multi-center
research trials, there was a wide variety between IRBs in
the types of amendments requested (protocol revisions,
patient information sheets and consent forms, recruit-
ment method, compensation arrangements and scientific
issues), but that the overall inter-IRB approval rate was
consistently high in all the reviewed reports, ranging be-
tween 83 to 95 % [13–15]. It is hard to estimate the
exact effect of the APP on the IDF IRB approval rate.
Based on the data presented in our report, the IDF IRB
approval rate without the pre-deliberation review would
apparently have been 92 % (345 proposals ultimately
approved or exempted, of 377 initially handled). When
including the APP’s contribution to screening and ex-
cluding proposals unfit for the IRB, the IRB’s approval
rate increased modestly to 94 %. This shows only the ef-
fect of the APP as a mechanism that decides if there is a
need for an IRB deliberation, similar to the USAISR ad-
visory panel. This rate is similar to the reports described
in the review. However, this screening and exclusion
process is only a small part of the overall APP process.
In order to address the scientific need for medical re-
search within the military, while maintaining the requis-
ite limitations on human subject research in the military
environment, the IDF drafted and implemented specific
orders and directives and founded the APP. These limi-
tations appear to significantly challenge researchers, as
33 % of all protocol revisions requested by the IDF MC
IRB were rooted in military-specific concerns regarding
the proposed method for recruiting soldiers for the
study or in the proposed method for obtaining their in-
formed consent. Furthermore, the fact that just over
one-third of the proposals required protocol revisions
and amendments despite APP review and preparation,
underscores the fervor with which the IRB protects both
volunteers and researchers from potentially unethical re-
search practices in the military environment.
There are two main limitations to the APP process.
First, even though the vast majority of the initial study
proposals (90 %) were amended by the APP, 47 % still
required some form of additional revision when consid-
ered by the IRB. As has been previously demonstrated
[12, 13, 15], different IRBs react differently to identical
research protocols, and as such, it is understandable that
a protocol approved by the APP might still be sent by
the IRB for certain revisions. Second is the issue of time.
As has been described [16], the time from proposal sub-
mission to IRB approval is a key component in the over-
all success of the study. The APP mechanism likely adds
some time to the overall length of the process. However,
the typical researcher in the IDF benefits from both eth-
ical and technical guidance in preparing research pro-
posals, inexperienced researchers arrive better prepared
for their meeting with the IRB, and APP turnaround
times are usually only several days long.
In this report we present the outcomes of all formal
research proposals submitted to the APP during
2013–2015. These do not include the approximately
250 additional research initiatives that were discussed
tentatively with the APP but that did not mature into
formal proposals within the study window.
Conclusions
We believe that the IDF APP mechanism has improved
the scientific rigor and ethical and academic standards
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of IDF MC research. The pre-IRB review allows re-
searchers to conduct medical research relevant to the
military population in the IDF in a way that maintains the
full integrity of soldiers’ informed consent. In addition, we
hope that by sharing IRB process data and approval and
rejection rates, medical institutions can help build and
support a benchmarking process through which individual
IRBs can appraise their own process measures relative to
those of their peers.
Abbreviations
APP: Advisory and preparatory process; IDF MC: Israel defense forces medical
corps; IRB: Institutional review board; USAISR: United States army institute of
surgical research
Funding
There was no funding for this research.
Availability of data and materials
The data cannot be shared freely due to military restrictions. Please contact
the corresponding author if you seek specific datum.
Authors’ contributions
AH and RK carried out the data collection, and with DD and TB drafted the
manuscript. NY and NP participated in the design of the study and performed
the statistical analysis. MH conceived the study, and participated in its design
and coordination and helped draft the manuscript. All authors read and
approved the final manuscript.
Authors’ information
Ayal Hassidim served as a physician with the IDF Medical Corps during the
study period and is currently a resident in plastic and reconstructive surgery
at the Hadassah Medical Center, Jerusalem. Raeed Kayouf serves as secretary
of the IDF IRB. Nirit Yavnai is chief scientist of the IDF Medical Corps. Naomi
Panush served as epidemiologic advisor for the APP during the study period.
David Dagan is the Surgeon General of the IDF and ultimately approves all
research proposals in the IDF MC. He also chaired the IDF IRB during part of
the study period. Tarif Bader is the Deputy Surgeon General of the IDF and
currently chairs the IDF IRB. Michael Hartal heads the IDF Medical Corps’
Academy and Research Branch, which is charged with oversight of all
research activities within the IDF Medical Corps.
Competing interests
The authors declare that they have no competing interests.
Author details
1Israel Defense Forces Medical Corps, Ramat Gan, Israel. 2Department of
Plastic and Reconstructive Surgery, Hadassah-Hebrew University Medical
Center, Jerusalem, Israel. 3Department of Military Medicine, Faculty of
Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Received: 24 October 2015 Accepted: 13 October 2016
References
1. Hurran E. Patients’ rights: from alder Hey to the Nuremberg code. History
and policy. 2002. p. 1–10.
2. Association GAotWM. WMA declaration of Geneva. 1948.
3. WMA Declaration of Helsinki Ethical Principles for Medical Research
Involving Human Subjects [database on the Internet]1968. Available from:
http://www.wma.net/en/30publications/10policies/b3/index.html.
Accessed 11 Nov 2014
4. Services USDoHaH. Code of Federal Regulations - Title 45 Public Welfare
CFR 46. 1981. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.
html. Accessed 3 May 2015 2015.




6. Platteborze LS, Young-McCaughan S, King-Letzkus I, McClinton A, Halliday A,
Jefferson TC. Performance improvement/research advisory panel: a model
for determining whether a project is a performance or quality improvement
activity or research. Mil Med. 2010;175(4):289–91.
7. First Press release of the IMA about the Anthrax trial Israel Medical
Association. 2007. http://www.ima.org.il/ima/formstorage/type1/antrax.pdf.
Accessed 22 Oct 2016.
8. Committee IMAE. the Anthrax trial - final summery. 2008.
9. supreme court petition physician for human rights versus the minister of




D7%97%D7%99%D7%99%D7%9C%D7%99/?pr=391. Accessed 22 Oct 2016.
10. Medical Treatment in the IDF a review. 2015. http://www.law.idf.il/163-
7173-he/Patzar.aspx. Accessed 22 Oct 2016.
11. Adams P, Kaewkungwal J, Limphattharacharoen C, Prakobtham S, Pengsaa K,
Khusmith S. Is your ethics committee efficient? using “IRB metrics” as a self-
assessment tool for continuous improvement at the faculty of tropical
medicine. Thailand: Mahidol University; 2014.
12. Matheson LA, Huber AM, Warner A, Rosenberg AM. Ethics application
protocols for multicentre clinical studies in Canada: a paediatric
rheumatology experience. Paediatr Child Health. 2012;17(6):313.
13. Edwards SJ, Stone T, Swift T. Differences between research ethics
committees. Int J Technol Assess Health Care. 2007;23(01):17–23.
14. Green LA, Lowery JC, Kowalski CP, Wyszewianski L. Impact of institutional
review board practice variation on observational health services research.
Health Serv Res. 2006;41(1):214–30.
15. Vick CC, Finan KR, Kiefe C, Neumayer L, Hawn MT. Variation in institutional
review processes for a multisite observational study. Am J Surg. 2005;
190(5):805–9.
16. Conforti L, Ross K, Hess B, Lynn L, Holmboe E, editors. Length of time
needed for institutional review board approval or exemption of quality
improvement projects among subset of US training programs. Academy for
Healthcare Improvement Symposium. Pennsylvania: The American Board of
Internal Medicine Philadelphia; 2008.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Hassidim et al. Israel Journal of Health Policy Research  (2016) 5:53 Page 7 of 7
